We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

15 hedge funds and large institutions have $12.6M invested in Virtus Biotech ETF in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

17% more capital invested

Capital invested by funds: $10.7M → $12.6M (+$1.83M)

7% more funds holding

Funds holding: 14 → 15 (+1)

1.99% more ownership

Funds ownership: 40.97% → 42.96% (+2%)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$691K
2
RWB
RMR Wealth Builders
New Jersey
+$85.6K
3
UBS Group
UBS Group
Switzerland
+$45.2K
4
Stifel Financial
Stifel Financial
Missouri
+$18.3K
5
SMG
Smart Money Group
Texas
+$9.03K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$267K
2
LPL Financial
LPL Financial
California
-$16.7K
3
FAIM
Financial Advocates Investment Management
Washington
-$12.8K
4
PFS
Prospera Financial Services
Texas
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$5.9M -$267K -5,206 -4%
SMG
2
Smart Money Group
Texas
$3.54M +$9.03K +176 +0.3%
Citadel Advisors
3
Citadel Advisors
Florida
$1.13M +$691K +13,481 +172%
FAIM
4
Financial Advocates Investment Management
Washington
$606K -$12.8K -250 -2%
Stifel Financial
5
Stifel Financial
Missouri
$431K +$18.3K +357 +5%
LPL Financial
6
LPL Financial
California
$389K -$16.7K -326 -4%
UBS Group
7
UBS Group
Switzerland
$127K +$45.2K +882 +58%
Morgan Stanley
8
Morgan Stanley
New York
$109K +$5.13K +100 +5%
NFG
9
Next Financial Group
Texas
$107K +$359 +7 +0.4%
RWB
10
RMR Wealth Builders
New Jersey
$89K +$85.6K +1,669 New
Osaic Holdings
11
Osaic Holdings
Arizona
$86K – – –
FWM
12
Focused Wealth Management
New York
$37K – – –
SWA
13
SOA Wealth Advisors
New York
$8K +$7.18K +140 New
CFB
14
Cullen/Frost Bankers
Texas
$4K – – –
Wells Fargo
15
Wells Fargo
California
$4K – – –
PFS
16
Prospera Financial Services
Texas
– -$5K -110 Closed

BBP Hedge Fund Activity: Q4 2020 in Review

15 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q4 2020, worth a combined $12.6M — up 17% from $10.7M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BBP positions and 1 closed out — a net gain of 1 holder — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $691K. The largest seller was Royal Bank of Canada, cutting an estimated $267K.

  • 15 institutional investors held Virtus Biotech ETF (BBP) as of Q4 2020, up from 14 in Q3 2020.
  • Funds reported $12.6M of Virtus Biotech ETF stock for Q4 2020, up 17% quarter-over-quarter.
  • 2 funds opened new Virtus Biotech ETF positions in Q4 2020 and 1 closed out, a net change of +1 holder.
  • The largest Virtus Biotech ETF buyer in Q4 2020 was Citadel Advisors, an estimated $691K added.
  • The largest Virtus Biotech ETF seller in Q4 2020 was Royal Bank of Canada, an estimated $267K sold.

Based on aggregated 13F filings for Q4 2020.